Systematic Review on Customized and Non-customized Device Techniques for the Endovascular Repair of the Aortic Arch

医学 主动脉弓 主动脉修补术 死亡率 外科 动脉瘤 主动脉
作者
Petroula Nana,Κωνσταντίνος Σπανός,Konstantinos Dakis,Athanasios D. Giannoukas,Tilo Kölbel,Stéphan Haulon
出处
期刊:Journal of Endovascular Therapy [SAGE Publishing]
卷期号:31 (4): 505-521 被引量:17
标识
DOI:10.1177/15266028221133701
摘要

Purpose: Open repair remains the standard of care for aortic arch pathologies. However, endovascular management became an attractive alternative for high-risk patients. This study aimed to assess the outcomes of the available endovascular techniques for aortic arch pathology management. Materials and Methods: A search of the English literature (2000–2022) using PubMed, EMBASE, via Ovid, and CENTRAL databases (February 1, 2022) was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Studies reporting on patients with aortic arch pathologies managed with custom-made devices ([CMDs] fenestrated or branched thoracic endovascular aortic repair [F/BTEVAR]) and non-CMDs (parallel graft or surgeon-modified FTEVAR) were eligible. Studies reporting on hybrid or open repair were excluded. Studies’ quality was assessed using the Newcastle-Ottawa Scale. Primary outcomes were technical success, 30 day mortality, and cerebrovascular events (CVEs). Secondary outcomes were re-intervention and mortality during follow-up. Results: Thirty studies (2135 patients) were included. Treatment indications were mainly dissections (652 cases [48.0%, 652/1358]; 90 type A, 506 type B; 364 acute, 163 chronic) and aneurysms (46.9%, 582/1239). Five studies (211 patients) reported on FTEVAR and 10 (388 patients) on BTEVAR. For FTEVAR, technical success rate was 98.3%. Thirty-day mortality was 3.8% and CVE rate was 12.3%. Ten deaths (9.7%) and 19 re-interventions (9%) were recorded during follow-up (24 months). Regarding BTEVAR, technical success rate was 98.7%, and 30 day mortality and CVE rates were 5.4% and 11.0%, respectively. During follow-up (27 months), 64 deaths (18.7%) and 33 re-interventions (9.6%) were recorded. Parallel graft technique was reported in 11 studies (901 patients). Technical success rate was 76.4%. Thirty-day mortality was 3.9% and 32 (4.3%) CVEs were recorded. Thirty-five deaths (4.4%) and 43 re-interventions (5.5%) were reported during follow-up (27 months). Surgeon-modified FTEVAR was described in 5 studies (635 patients). Technical success rate was 91.6%. At 30 days, 15 deaths (2.3%) and 22 CVEs (3.5%) were recorded. During follow-up (19 months), 26 deaths (4.2%) and 21 re-interventions (3.6%) were detected. Conclusions: Endovascular arch repair presented a variable technical success; >95% for F/BTEVAR; ≤90% for non-CMDs. Acceptable 30 day mortality rates were reported. Cerebrovascular event rates ranged up to 10%. These findings, adjacent to the estimated midterm mortality and re-interventions, set the need for further improvement. Clinical Impact Endovascular arch repair gains popularity as a valuable alternative, especially in patients considered unfit for open repair. According the available literature, any endovascular technique, including custom-made or off-the-shelf solutions, may be applied successfully, with acceptable early mortality. However, the perio-operative cerebrovascular event rate is still an issue, indicating the need for further advancements.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ifanyz发布了新的文献求助10
刚刚
KYRIELIU发布了新的文献求助10
刚刚
星星发布了新的文献求助10
1秒前
啊啊啊发布了新的文献求助10
1秒前
1秒前
1秒前
清秀寄风完成签到,获得积分10
2秒前
伶俐书雁完成签到,获得积分20
2秒前
ZHQ发布了新的文献求助10
3秒前
猇会不会完成签到,获得积分10
3秒前
3秒前
两面性发布了新的文献求助20
3秒前
3秒前
4秒前
4秒前
归尘发布了新的文献求助10
4秒前
4秒前
谦让寻绿发布了新的文献求助10
4秒前
JamesPei应助Liu采纳,获得10
4秒前
like发布了新的文献求助10
5秒前
5秒前
6秒前
任白993发布了新的文献求助10
6秒前
liduoduo完成签到,获得积分10
6秒前
XXXX驳回了烟花应助
6秒前
梧桐完成签到,获得积分10
6秒前
6秒前
可玩性发布了新的文献求助10
6秒前
Exile完成签到,获得积分10
6秒前
6秒前
Lucas应助Valky采纳,获得10
6秒前
小二郎应助科研眼镜蛇采纳,获得10
7秒前
ifanyz完成签到,获得积分10
7秒前
8秒前
8秒前
FRANKFANG发布了新的文献求助30
8秒前
枫叶完成签到,获得积分10
8秒前
Cluneeeee发布了新的文献求助10
9秒前
善学以致用应助黑黑黑采纳,获得10
9秒前
9秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974779
求助须知:如何正确求助?哪些是违规求助? 3519193
关于积分的说明 11197417
捐赠科研通 3255311
什么是DOI,文献DOI怎么找? 1797760
邀请新用户注册赠送积分活动 877150
科研通“疑难数据库(出版商)”最低求助积分说明 806187